Inflamax introduces ePDAT for real-time PRO data collection

Article

New tablet facilitates and standardizes patient reported outcomes data collection.

Toronto, Ontario-Inflamax Research has introduced its electronic Patient Data Acquisition Tablet (ePDAT) which not only facilitates but standardizes patient reported outcomes (PRO) data collection across multi-center clinical trials.

The validated ePDAT system provides a graphical user interface via a touchscreen tablet computer designed to provide an improved user experience. The system was designed to enhance user experience, accuracy, and quality while ensuring compliance with FDA and EMA requirements for validated ePRO data collection tools. ePDAT is fully CFR21 part 11 compliant.

PRO data can be collected by on-screen questionnaires, visual analog scales (VAS), response time, coordination tasks, high-resolution image capture, and evaluator interview via video conferencing.

Software architecture allows patient data to be recorded in real-time via the tablet’s cellular wireless connection to the company’s secure database servers. Data is also stored locally on the tablet as backup. 

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Carolyn Majcher, OD, FAAO, detailed a talk she gave alongside Mary Beth Yackey, OD, at Optometry's Meeting 2025.
Shelby Brogdon, OD, details opportunities for practices to answer the patient's concerns from the chair before they hit the internet for their contact lens needs.
Christi Closson, OD, FAAO, shares her excitement for the new Acuvue Oasys MAX 1-Day multifocal for astigmatism
Karen R. Hoffman, OD, shares how customizable scleral lenses can transform vision for patients with complex corneas, achieving 20/20 outcomes and enhanced comfort.
Janna Pham, OD, shares key takeaways from a corneal tomography session she presented alongside Travis Pfeifer, OD, and Matthew McGee, OD.
Jacob Lang, OD, FAAO, details early symptom relief demonstrated in as early as day 1 during AOA's Optometry's Meeting 2025.
When Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, began fitting scleral lenses 20 years ago, there was limited knowledge about conjunctival characteristics, scleral shape, and lens behavior.
Ioussifova details what sets Johnson & Johnson's new lens apart from the rest, which was launched at the American Optometric Association's Optometry's Meeting 2025.
Alongside Rachel Steele, OD, Rafieetary outlines what to look for in blurred disc margins and the importance of acting fast and sending patients to the ED when needed.
Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, emphasized that every staff member should play a role in myopia management during his presentation at Optometry's Meeting 2025.
© 2025 MJH Life Sciences

All rights reserved.